Skip to main content
. 2019 Jun 11;3(8):1518–1530. doi: 10.1210/js.2019-00200

Table 2.

Presentation and Symptoms of Adult Patients With AMH and its Subgroups Compared With Adult Patients With PCCs Without AMH

All AMHs (n = 19) P Value vs PCCs AMHs Without PCC (n = 7) P Value vs PCCs AMHs With PCC (n = 12) P Value vs PCCs PCCs Without AMH (n = 95)
Presentation
 Incidentaloma, n (%) 7 (37) 0.025 3 (43) 0.365 4 (33) 0.021 64 (67)
 Suspicion of PCC, n (%) 4 (21) 0.522 2 (29) 0.798 2 (17) 0.288 30 (32)
 Screening, n (%) 8 (42) <0.001 2 (29) 0.003 8 (67) <0.001 1 (1)
PCC symptoms
 Paroxysmal symptoms, n (%) 9 (47) 0.395 2 (29) 0.198 7 (58) 1 58 (61)
 Headaches, n (%) 3 (16) 0.081 0 (0) 0.088 3 (25) 0.365 38 (40)
 Palpitations, n (%) 7 (37) 0.175 1 (14) 0.041 6 (50) 0.761 54 (57)
 Sweating, n (%) 5 (26) 0.234 3 (43) 0.745 2 (17) 0.117 42 (44)
 Pallor, n (%) 2 (11) 0.777 0 (0) 0.871 2 (17) 0.357 9 (9)
 Anxiety, n (%) 8 (42) 0.867 2 (29) 0.569 6 (50) 1 45 (47)
 Feeling warm/flush, n (%) 2 (11) 0.311 2 (29) 0.844 0 (0) 0.066 23 (24)
 Nausea, n (%) 1 (5) 0.226 1 (14) 0.900 0 (0) 0.119 19 (20)
 Weight loss, n (%) 1 (5) 0.399 0 (0) 0.588 1 (8) 0.689 15 (16)
 Tiredness, n (%) 5 (26) 0.926 3 (43) 0.705 2 (17) 0.507 27 (28)
 Tremor, n (%) 1 (5) 0.457 0 (0) 0.600 1 (8) 0.547 14 (15)
 Orthostatic symptoms, n (%) 0 (0) 0.037 0 (0) 0.312 0 (0) 0.066 23 (24)
 Number of PCC symptoms 2.0 (0.3–3.0) 0.031 1.0 (0–3.0) 0.049 2.0 (1.0–3.5) 0.267 3.0 (1.0–5.0)
 Classic triad, n (%) 1 (5) 0.195 0 (0) 0.389 1 (8) 0.453 20 (21)
Cushing symptoms,a n (%) 2 (11) 0.114 2 (29) 0.003 0 (0) 1 1 (1)
Asymptomatic, n (%) 5 (26) 0.097 3 (43) 0.042 1 (8) 1 9 (9)

The patients screened due to familiar disease had a previously known RET mutation (MEN2A). The classic triad with paroxysmal symptoms was defined as headaches, sweating, and palpitation. Boldface indicates P < 0.05; italics indicate P = 0.05–0.09.

a

Symptoms that could indicate Cushing syndrome (e.g., moon face, fat deposition at the supraclavicular fossa/between the shoulders/abdomen, acne, skin atrophy, depression, fatigue, insomnia, concentration difficulties, easy bruising, proximal muscle weakness, muscle and joint pain, and amenorrhea).